ArticleMedicine2025
Investigating the correlation between tea intake and glioblastoma: A Mendelian randomization study.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Glioblastoma is a highly aggressive brain tumor with poor prognosis. Epidemiological studies suggest lifestyle factors, including tea intake, might influence glioblastoma risk. This study investigates the causal relationship between tea intake and glioblastoma risk using 2-sample Mendelian randomization (MR) analysis. Summary data from genome-wide association studies were used for MR analysis, employing single nucleotide polymorphisms (SNPs) associated with tea intake as instrumental variables. The causal effect of tea intake on glioblastoma risk was estimated using inverse-variance weighted (IVW), MR-Egger, weighted mode, and weighted median methods. Heterogeneity and pleiotropy were assessed using Cochran Q test and MR-Egger regression intercept. Forty SNPs were identified as instrumental variables. The IVW method showed no evidence of a causal association between tea intake and glioblastoma risk (OR = 0.6; 95% CI = 0.02-18.21; P = .7768). Supplementary analyses using MR-Egger, weighted median, and weighted mode methods were consistent with the IVW results. Leave-one-out analysis confirmed result stability, and the funnel plot indicated no pleiotropy. This MR analysis does not support a causal relationship between tea intake and glioblastoma risk. Rigorous methods are crucial for assessing causality in observational studies. Further research is needed to explore the impact of tea intake on glioblastoma using diverse study designs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.